A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL
Enrollment

5,813

Participants

Timeline

Start Date

January 16, 2014

Primary Completion Date

February 23, 2017

Study Completion Date

February 23, 2017

Conditions
Diabetes Mellitus, Type 2Albuminuria
Interventions
DRUG

Placebo

One placebo capsule taken orally (by mouth) once daily for 156 weeks

DRUG

Canagliflozin, 100 mg

One 100 mg capsule taken orally (by mouth) once daily

DRUG

Canagliflozin, 300 mg

One 300 mg capsule taken orally (by mouth) once daily

Trial Locations (342)

Unknown

Little Rock

Carmichael

Concord

Pismo Beach

Roseville

Thousand Oaks

Denver

Hollywood

Jacksonville

Miami

New Port Richey

Opa-locka

Orlando

Palm Harbor

Tampa

Meridian

Chicago

Valparaiso

Topeka

Louisville

Mandeville

Metairie

Elkridge

Flint

Picayune

Kansas City

St Louis

Washington

Omaha

Las Vegas

Cornelius

Hickory

Mooresville

Canal Fulton

Franklin

Mason

Oklahoma City

Beaver

Levittown

Norristown

Pittsburgh

Tipton

Greer

Jefferson City

Austin

Pearland

Bountiful

Draper

Salt Lake City

West Jordan

South Burlington

Falls Church

Norfolk

Virginia Beach

Spokane

Milwaukee

Wauwatosa

Buenos Aires

Ciudad de Buenos Aires

Córdoba

Mar del Plata

Morón

Rosario

Zarate, Buenos Aires

Box Hill

Cairns

Daw Park

Freemantle

Liverpool

Melbourne

Newcastle

Sherwood

Sydney

Tasmania

Woden

Woolloongabba

Bonheiden

Bruges

Edegem

Ghent

La Louvière

Leuven

Liège

Liÿge

Merksem

Ransart

Roeselare

Tessenderlo

Belém

Belo Horizonte

Campinas

Caxias do Sul

Curitiba

Fortaleza

Mogi das Cruzes

Passo Fundo

Porto Alegre

Rio de Janeiro

São José do Rio Preto

São Paulo

Coquitlam

Winnipeg

Halifax

Guelph

Mississauga

Oshawa

Sarnia

Thornhill

Toronto

Laval

Lévis

Québec

Saint Marc Des Carriéres

Sherbrooke

Westmont

Saskatoon

Baotou

Beijing

Hangzhou

Jinan

Shenyang

Wuxi

Beroun

Ostrava

Pilsen

Prague

Znojmo

Amiens

Bois-Guillaume

Bordeaux

Dijon

Grenoble

La Rochelle

Le Creusot

Narbonne

Paris

Poitiers

Aschaffenburg

Aßlar

Bad Oeynhausen

Dortmund

Dresden

Freiburg im Breisgau

Hanover

Kassel

Mainz

Neuwied

Saarbrücken

Villingen-Schwenningen

Balatonfüred

Budapest

Dunaújváros

Eger

Kecskemét

Nagykanizsa

Pécs

Székesfehérvár

Szikszó

Szombathely

Zalaegerszeg

*Osenza*

Arenzano

Bologna

Catanzaro

Chieri (Torino)

Florence

Messina

Milan

Napoli

Ravenna

Roma

Sesto San Giovanni (Milano)

Verona

Batu Caves

George Town

Ipoh

Kelantan

Kota Bharu

Kuala Lumpur

Kuching

Aguascalientes

Celaya

Cuernavaca

Culiacán

Guadalajara

México

Pachuca

Querétaro

San Luis Potosí City

Tampico

Almelo

Almere Stad

Amersfoort

Amsterdam

Dordrecht

Eindhoven

Groningen

Hardenberg

Hoogeveen

Hoogezand

Kloosterhaar

Leiden

Meppel

Poortvliet

Rotterdam

Utrecht

Velp

Waalwijk

Wamel

Zoetermeer

Zwijndrecht

Auckland

Christchurch

Newtown

Palmerston North

Rotorua

Tauranga

Wellington

Bialystok

Bydgoszcz

Chrzanów

Gdansk

Grodzisk Mazowiecki

Katowice

Krakow

Lublin

Oświęcim

Torun

Tychy

Warsaw

Wroclaw

Ponce Pr

Trujillo Alto

Arkhangelsk

Barnaul

Chelyabinsk

Kemerovo

Nizhny Novgorod

Penza

Rostov-on-Don

Saint Petersburg

Samara

Saratov

Smolensk

Syktyvkar

Tyumen

Vsevolzhsk

Yaroslavl

Ansan

Bucheon-si

Busan

Changwon

Cheongju-si

Daegu

Gyeonggi-do

Iksan

Incheon

Jeonju

Seongnam-si

Seoul

Suwon

Ulsan

Wŏnju

A Coruña

Alcalá de Henares

Alicante

Almería

Alzira

Barcelona

Ciudad Real

Córdoba

Ferrol

Figueres

Galdakao

Madrid

Málaga

Móstoles

Palma de Mallorca

Sabadell

San Sebastián de los Reyes

Sant Joan d'Alacant

Santa Cruz de Tenerife

Santiago de Compostela

Segovia

Seville

Valencia

Viladecans

Borås

Gothenburg

Helsingborg

Karlstad

Linköping

Lund

Malmo

Stockholm

Uddevalla

Uppsala

Vällingby

Västra Frölunda

Kaohsiung County

Taichung

Tainan City

Taipei

Tiachung

Xindian

Cherkasy

Chernivtsy

Dnipropetrovsk

Ivan-Frankivsk

Ivano-Frankivsk

Kharkiv

Kiev

Kyiv

Lviv

Odesa

Poltava

Sumy

Ternopil

Uzhhorod

Vinnitsa

Vinnytsia

Zaporizhzhia

Zaporizhzhya

Addlestone

Belfast

Birmingham

Blackburn

Bristol

Bury St Edmunds

Chesterfield

Derby

Doncaster

Ipswich

Leicester

Liverpool

Manchester

Salford

Taunton

Torquay

Truro

Wellingborough

Welwyn Garden City

All Listed Sponsors
collaborator

The George Institute for Global Health, Australia

OTHER

lead

Janssen Research & Development, LLC

INDUSTRY

NCT01989754 - A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter